免疫介导性皮肤病：未来的治疗展望。
Immune-Mediated Skin Diseases: Future Therapeutic Perspectives.
机构信息
Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy.
出版信息
Medicina (Kaunas). 2023 Oct 8;59(10):1787. doi: 10.3390/medicina59101787.
Abstract
Immuno-mediated skin diseases are a common and clinically heterogeneous group of cutaneous conditions [...].
摘要
免疫介导的皮肤疾病是一组常见且具有临床异质性的皮肤疾病[...]。
相似文献
1
Immune-Mediated Skin Diseases: Future Therapeutic Perspectives.免疫介导性皮肤病：未来的治疗展望。
Medicina (Kaunas). 2023 Oct 8;59(10):1787. doi: 10.3390/medicina59101787.
2
Transdermal immunomodulation: Principles, advances and perspectives.经皮免疫调节：原理、进展与展望。
Adv Drug Deliv Rev. 2018 Mar 1;127:3-19. doi: 10.1016/j.addr.2018.03.010. Epub 2018 Mar 29.
3
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.血液系统恶性肿瘤患者的免疫介导性皮肤病：全面综述。
Am J Clin Dermatol. 2020 Dec;21(6):833-854. doi: 10.1007/s40257-020-00553-9.
4
Therapeutic targeting of Toll-like receptors in cutaneous disorders.皮肤疾病中Toll样受体的治疗靶向作用
Expert Opin Ther Targets. 2015;19(12):1651-63. doi: 10.1517/14728222.2015.1069275. Epub 2015 Jul 18.
5
[Pharma clinics. Medication of the month. Imiquimod (Aldara): an immunomodulator for the skin].
Rev Med Liege. 2002 Feb;57(2):116-8.
6
Immune complex disease of the skin.
Cutis. 1977 Jul;20(1):83-6.
7
Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use.白细胞介素-10在皮肤疾病中的作用：对其病理生理重要性及治疗用途的影响
Arch Dermatol Res. 1999 Dec;291(12):628-36. doi: 10.1007/s004030050467.
8
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile.炎症性和免疫介导性皮肤病的生物治疗：安全性概况。
Curr Drug Saf. 2016;11(1):12-21. doi: 10.2174/1574886310666151014121732.
9
TRP channels in the skin.皮肤中的瞬时受体电位通道
Br J Pharmacol. 2014 May;171(10):2568-81. doi: 10.1111/bph.12569.
10
The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases.NLRP3 炎性小体在感染相关、免疫介导和自身免疫性皮肤病中的作用。
J Dermatol Sci. 2020 Jun;98(3):146-151. doi: 10.1016/j.jdermsci.2020.03.001. Epub 2020 Mar 6.
本文引用的文献
1
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.分析影响特应性皮炎成年患者度普利尤单抗维持治疗率的预测因素：来自意大利多中心研究的结果。
J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685.
2
Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib.奥达特罗单抗治疗特应性皮炎和溃疡性结肠炎疗效显著。
Medicina (Kaunas). 2023 Mar 10;59(3):542. doi: 10.3390/medicina59030542.
3
Spontaneous Reversal of Vitiligo, a Rare Phenomenon Reported in a Case in Saudi Arabia with an Insight into Metabolic Biochemical Derangements.沙特阿拉伯一例罕见病例报告的白癜风自发逆转，深入探讨代谢生化紊乱。
Medicina (Kaunas). 2023 Feb 22;59(3):427. doi: 10.3390/medicina59030427.
4
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review.生物药物治疗弥漫性皮肤系统性硬化症的影响：系统评价。
Medicina (Kaunas). 2023 Jan 27;59(2):247. doi: 10.3390/medicina59020247.
5
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis.度普利尤单抗对中重度特应性皮炎成人患者性欲的影响。
Medicina (Kaunas). 2022 Nov 23;58(12):1708. doi: 10.3390/medicina58121708.
6
Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?粒细胞采集：它能与抗 PD-1 疗法治疗黑色素瘤相关联吗？
Medicina (Kaunas). 2022 Oct 6;58(10):1398. doi: 10.3390/medicina58101398.
7
Aseptic Abscess Syndrome in Rheumatoid Arthritis Patient.类风湿关节炎患者的无菌性脓肿综合征。
Medicina (Kaunas). 2022 Sep 27;58(10):1354. doi: 10.3390/medicina58101354.
8
Small-molecule-based immunotherapy for immunologically mediated skin conditions.基于小分子的免疫疗法治疗免疫介导的皮肤疾病。
Immunotherapy. 2020 Apr;12(6):417-429. doi: 10.2217/imt-2019-0190. Epub 2020 Apr 19.
Zotero 插件